UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-7977 NORDSON CORPORATION (Exact name of registrant as specified in its charter) ___________________________________________________ Ohio (State or other jurisdiction of incorporation or organization) 28601 Clemens Road Westlake, Ohio (Address of principal executive ...

Financial Data and Key Metrics Changes - First quarter 2022 sales were $609 million, a 16% increase from $527 million in the prior year, driven by 16% organic volume growth and 4% from the NDC acquisition [7][12] - Gross profit for Q1 2022 was $340 million, or 56% of sales, compared to $290 million or 55% of sales in the prior year, reflecting a 100 basis point increase in gross margin [8][11] - Operating profit was $156 million, or 26% of sales, a 44% increase from the prior year [10] - Net income totaled $120 million, or $2.05 per share, with adjusted earnings per share of $2.07, a 57% increase from the prior year [11][12] Business Line Data and Key Metrics Changes - Industrial Precision Solutions (IPS) sales were $324 million, a 12% increase year-over-year, with organic volume growth of 12% and an 8% contribution from the NDC acquisition [12][14] - Advanced Technology Solutions (ATS) sales increased 20% to $285 million, with organic sales volume growth of 21% [15][16] - IPS operating profit was $104 million, or 32% of sales, a 24% increase from the prior year [14] - ATS operating profit was $76 million, or 27% of sales, a 62% increase from the prior year [16] Market Data and Key Metrics Changes - All regions delivered organic growth in Q1 2022, with particularly strong demand in Asia and Europe [7][14] - The backlog grew to over $900 million, driven by strong order entry in electronics, industrial, and medical end markets [22] Company Strategy and Development Direction - The company is focused on deploying the NBS Next growth framework to enhance customer engagement and operational efficiency [19][25] - The leadership team is advancing the implementation of the Ascend strategy to drive sustainable, profitable growth [25] - The company remains active in M&A with a healthy pipeline, focusing on scaling its medical business and expanding test and inspection capabilities [45][95] Management's Comments on Operating Environment and Future Outlook - Management noted that supply chain constraints and labor shortages are expected to persist into the second half of the year, but improvements are anticipated [23][30] - For Q2 2022, the company expects sales growth in the range of 6% to 10% compared to Q2 2021, with adjusted earnings per diluted share between $2.20 and $2.30 [24][25] - Full-year revenue growth is projected to be in the range of 7% to 10%, with adjusted earnings per diluted share growth of 14% to 18% over fiscal 2021 [25] Other Important Information - Free cash flow for the quarter was $106 million, with a conversion rate on net income of 88% [17] - The company ended the quarter with cash totaling $171 million and net debt of $637 million, resulting in a leverage ratio of 0.8 times based on trailing 12 months EBITDA [18] Q&A Session Summary Question: Price cost spread and its future cadence - Management indicated that the negative price cost mismatch of 100 basis points in Q1 is expected to improve, potentially halving in Q2 and becoming neutral in the back half of the year [28] Question: Supply chain and labor visibility - Management noted that supply chain issues are not uniform across all businesses, with some improvement expected as the year progresses, particularly in labor availability [30] Question: Backlog normalization - Management expects supply chain normalization to occur in the second half of the year, with the current backlog being inflated due to large system orders extending into 2023 [41][42] Question: Capital allocation and M&A strategy - The company remains disciplined in its M&A approach, focusing on strategic acquisitions that align with its growth objectives, while also returning capital through dividends and share buybacks [45][94] Question: Performance of NDC Technologies acquisition - The integration of NDC Technologies into IPS is progressing well, with strong alignment in end markets and growth opportunities identified post-acquisition [52] Question: Trends in elective surgeries and biopharma - Elective surgeries are recovering, and the biopharma business is strong, driven by vaccine production and gene therapies [55] Question: Geographic performance and growth - Significant strength was noted in Europe and Asia, while the U.S. and Japan showed more modest growth, with Japan still recovering from COVID impacts [58] Question: ATS margins and sustainability - ATS margins were strong due to volume leverage and cost control measures, with favorable mix benefits particularly from the medical business [73]

ND INVESTOR PRESENTATION February 22, 2022 I NASDAQ: NDSN On November 1, 2021, Nordson closed its acquisition of NDC Technologies, a test and inspection business focused on measurement and controls solutions serving consumer non-durable, film extrusion & converting, cable & tubing and energy storage end markets. Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of ...

CyberOptics Corporation (CYBE) Q4 2021 Earnings Conference Call February 17, 2022 4:30 PM ET Company Participants Dr. Subodh Kulkarni - President and CEO Jeff Bertelsen - CFO, COO Conference Call Participants Rich Ryan - Colliers Greg Palm - Craig-Hallum Capital Group Eric Slade - Acme Analytics Ash Birla - Birla DK Capital Operator Good day, ladies and gentlemen, and welcome to the CyberOptics Fourth Quarter 2021 Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the confe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-7977 NORDSON CORPORATION (Exact name of Registrant as specified in its charter) Ohio (State of incorporation) 28601 Clemens Road Westlak ...

Company Overview and Financial Performance - CyberOptics' revenue grew at a compound annual growth rate (CAGR) of approximately 12% to reach $70.1 million in 2020[19, 23] - The company's revenue for the first nine months of 2021 was $70.7 million, reflecting a 33% year-over-year increase[20] - CyberOptics' Q4 2021 revenue guidance is between $19.0 million and $23.0 million, compared to $16.9 million in Q4 2020[20] - The company has a strong balance sheet with $33.5 million in cash and no debt[20] MRS Technology and Products - Multi-Reflection Suppression (MRS) products revenue in 2020 was $31.8 million, a 33% increase compared to 2019[24] - MRS products revenue for the first nine months of 2021 was $37.4 million, up 57% year-over-year[24] - CyberOptics received $10.5 million in new purchase orders for the MX3000™ systems since late 2020[24, 57] WaferSense® Sensors - WaferSense® sensors revenue in 2020 was $15.0 million, an 8% increase compared to 2019[24, 77] - WaferSense® sensors revenue for the first nine months of 2021 was $17.9 million, up 58% year-over-year[24, 77] Market Opportunities - The market opportunity for MRS-enabled systems is projected to grow to approximately $2.9 billion in 2025[31, 32] - The market for MRS and WaferSense® sensors is expected to grow at a CAGR of over 20% through 2025, reaching approximately $438 million in 2025[31, 32] - The memory module Final Vision Inspection (FVI) system market is projected to be around $15 million+ per year for the next 5 years[32, 56, 58]

CyberOptics Corporation (CYBE) Q3 2021 Earnings Conference Call October 27, 2021 4:30 PM ET Company Participants Subodh Kulkarni - President & Chief Executive Officer Jeff Bertelsen - Chief Financial Officer & Chief Operating Officer Conference Call Participants Greg Palm - Craig-Hallum Capital Group Dick Ryan - Colliers Jaeson Schmidt - Lake Street Operator Good day ladies and gentlemen and welcome to the CyberOptics Third Quarter 2021 Earnings Call. Today's conference is being recorded. At this time I'd l ...

Sales Performance - Worldwide sales for the three months ended July 31, 2021 were $646,858, an increase of 20.2% from $538,181 in the comparable period of 2020, driven by a 20.2% increase in organic sales volume [101]. - For the nine months ended July 31, 2021, worldwide sales were $1,762,962, an increase of 12.8% from $1,562,575 in the comparable period of 2020, driven by an 11.6% increase in organic sales volume [113]. - Sales outside the United States accounted for 68.8% of total sales in the three months ended July 31, 2021, compared to 65.9% in the same period of 2020 [102]. - Sales in the Asia Pacific region for the nine months ended July 31, 2021 increased by 24.3% to $510,609, driven by a 21.1% organic sales volume increase [114]. - Sales of the Industrial Precision Solutions segment for the nine months ended July 31, 2021 were $932,640, an increase of 11.7% from $835,038 in the comparable period of 2020 [120]. - Sales of the Advanced Technology Solutions segment for the nine months ended July 31, 2021 were $830,322, an increase of 14.1% from $727,537 in the comparable period of 2020 [122]. Profitability - Gross profit margin increased to 56.5% for the three months ended July 31, 2021, up from 52.2% in the comparable period of 2020, primarily due to favorable sales volume leverage and product mix [104]. - Operating profit for the three months ended July 31, 2021 was $188,276, representing an increase of 67.9% from $112,055 in the same period of 2020, with an operating margin of 29.1% [106]. - Operating profit for the nine months ended July 31, 2021 was $463,692, an increase of 48.6% from $312,177 in the same period of 2020, with an operating margin of 26.3% [117]. - Net income for the three months ended July 31, 2021 was $142,182, or $2.42 per diluted share, a 63.5% increase in net income and a 62.4% increase in diluted earnings per share compared to the same period of 2020 [108]. Cash Flow and Investments - Cash provided by operations during the nine months ended July 31, 2021, was $375,456, an increase from $309,958 for the same period in 2020 [129]. - Cash used in investing activities was $22,997 for the nine months ended July 31, 2021, significantly lower than $163,192 used in the comparable period of 2020 [130]. - Cash used in financing activities was $388,126 for the nine months ended July 31, 2021, compared to $75,404 in the same period of 2020 [131]. Future Outlook - Backlog entering the fourth quarter of fiscal year 2021 is approximately $700 million, or 70% above the prior year [134]. - The company expects full-year sales growth in fiscal 2021 to be approximately 11% to 12% over fiscal year 2020 [135]. - Full year 2021 earnings per diluted share is forecasted in the range of $7.75 to $7.95, representing a strong second half with year-over-year sales growth of 14% and earnings growth of 47% [135]. Tax and Debt - The effective tax rate for the three and nine months ended July 31, 2021, was 21.2% and 20.8%, respectively, compared to 8.9% and 16.0% for the same periods in 2020 [125]. - The decrease of $83,072 in pension obligations was primarily due to pension contributions during the second and third quarters of 2021 [132]. - Long-term debt decreased by $278,221 primarily due to the full repayment of the term loan due 2024 [132]. - The company was in compliance with all debt covenants at July 31, 2021 [133].

CyberOptics Corporation (CYBE) Q2 2021 Results Earnings Conference Call July 28, 2021 4:30 PM ET Company Participants Subodh Kulkarni - President and Chief Executive Officer Jeff Bertelsen - Chief Operating Officer, Vice President, Finance and Chief Financial Officer Conference Call Participants Greg Palm - Craig-Hallum Capital Group Richard Ryan - Colliers Securities Jaeson Schmidt - Lake Street Capital Orin Hirschman - AIGH Investment Partners Operator Good day and welcome to the CyberOptics Second Quarte ...

[PART I – FINANCIAL INFORMATION](index=4&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) [Financial Statements (Unaudited)](index=4&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS%20(UNAUDITED)) The company presents unaudited condensed consolidated financial statements and key accounting policies for the period ended April 30, 2021 [Condensed Consolidated Statements of Income](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) The company reported significant growth in sales, operating profit, and net income for the three and six months ended April 30, 2021 Consolidated Income Statement Highlights (in thousands, except per share data) | Metric | Three Months Ended April 30, 2021 | Three Months Ended April 30, 2020 | Six Months Ended April 30, 2021 | Six Months Ended April 30, 2020 | |:---|:---:|:---:|:---:|:---:| | Sales | $589,538 | $529,478 | $1,116,104 | $1,024,394 | | Operating Profit | $166,391 | $125,029 | $275,416 | $200,122 | | Net Income | $124,144 | $92,079 | $201,726 | $144,083 | | Diluted EPS | $2.12 | $1.58 | $3.44 | $2.47 | [Condensed Consolidated Balance Sheets](index=6&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets slightly decreased to $3.59 billion while shareholders' equity increased to $1.95 billion as of April 30, 2021 Balance Sheet Summary (in thousands) | Account | April 30, 2021 | October 31, 2020 | |:---|:---:|:---:| | Cash and cash equivalents | $133,320 | $208,293 | | Total current assets | $949,425 | $1,020,612 | | Goodwill | $1,720,990 | $1,713,354 | | Total assets | $3,594,910 | $3,674,656 | | Total current liabilities | $385,267 | $363,089 | | Long-term debt | $829,044 | $1,067,952 | | Total liabilities | $1,644,553 | $1,915,665 | | Total shareholders' equity | $1,950,357 | $1,758,991 | [Condensed Consolidated Statements of Cash Flows](index=9&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Operating cash flow was $247.7 million, with significant cash used for debt repayment, dividends, and share repurchases Cash Flow Summary for Six Months Ended (in thousands) | Activity | April 30, 2021 | April 30, 2020 | |:---|:---:|:---:| | Net cash provided by operating activities | $247,714 | $218,179 | | Net cash used in investing activities | ($13,681) | ($27,731) | | Net cash used in financing activities | ($310,333) | ($30,987) | | Effect of exchange rate changes on cash | $1,327 | ($4,370) | | **Net (decrease) increase in cash** | **($74,973)** | **$155,091** | [Notes to Condensed Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) The notes detail key accounting policies, recent acquisitions and divestitures, segment realignment, and other financial items - On February 1, 2021, the company completed the sale of its screws and barrels product line, which was part of the Industrial Precision Solutions segment; an impairment charge of **$87.4 million** was recorded in 2020 related to this divestiture[42](index=42&type=chunk)[44](index=44&type=chunk) - The company acquired vivaMOS Ltd. in September 2020 for **$17.2 million** and Fluortek, Inc. in June 2020 for **$125.3 million**; both acquisitions are reported in the Advanced Technology Solutions segment[40](index=40&type=chunk)[41](index=41&type=chunk) - The company realigned its structure from three to two operating segments in Q2 2020: **Industrial Precision Solutions (IPS)** and **Advanced Technology Solutions (ATS)**[76](index=76&type=chunk) Segment Operating Profit (in thousands) | Segment | Three Months Ended April 30, 2021 | Three Months Ended April 30, 2020 | Six Months Ended April 30, 2021 | Six Months Ended April 30, 2020 | |:---|:---:|:---:|:---:|:---:| | Industrial Precision Solutions | $104,283 | $76,454 | $187,686 | $132,858 | | Advanced Technology Solutions | $76,585 | $58,689 | $123,786 | $90,976 | [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=24&type=section&id=ITEM%202.%20MANAGEMENT'S%20DISCUSSION%20AND%20ANALYSIS%20OF%20FINANCIAL%20CONDITION%20AND%20RESULTS%20OF%20OPERATIONS) Management discusses strong financial performance driven by organic sales growth and provides an optimistic outlook for fiscal year 2021 - The company continues to operate all production facilities during the COVID-19 pandemic, supporting critical infrastructure sectors; while facing some manufacturing inefficiencies and supply chain disruptions, the company's **diversification has provided resilience**[99](index=99&type=chunk) Full Year 2021 Outlook | Metric | Forecast Range | |:---|:---:| | Full Year Sales Growth (vs. 2020) | 8% to 10% | | Full Year Diluted EPS | $7.20 to $7.50 | [Results of Operations](index=24&type=section&id=Results%20of%20Operations) Sales grew significantly due to strong organic volume, while profitability improved from higher sales and a favorable divestiture impact - Gross margin for Q2 2021 increased to **57.3%** from 54.7% YoY, with **1.8 percentage points** of the improvement attributed to the divestiture of the screws and barrel product line[104](index=104&type=chunk) Q2 2021 Sales Growth Components | Component | Contribution | |:---|:---:| | Organic Sales Volume | +10.4% | | Currency Translation | +3.7% | | Acquisitions/Divestitures (Net) | -2.8% | | **Total Sales Growth** | **+11.3%** | H1 2021 Sales Growth Components | Component | Contribution | |:---|:---:| | Organic Sales Volume | +7.0% | | Currency Translation | +3.3% | | Acquisitions/Divestitures (Net) | -1.3% | | **Total Sales Growth** | **+9.0%** | [Financial Condition](index=27&type=section&id=Financial%20Condition) Strong operating cash flow was primarily used for net debt repayment of $250.1 million, dividends, and share repurchases - Long-term debt decreased by **$238.9 million** from October 31, 2020, mainly due to the full repayment of the term loan due in 2024[130](index=130&type=chunk) - Pension obligations decreased by **$56.5 million**, primarily due to pension contributions made during the second quarter of 2021[130](index=130&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=28&type=section&id=ITEM%203.%20QUANTITATIVE%20AND%20QUALITATIVE%20DISCLOSURES%20ABOUT%20MARKET%20RISK) Market risk exposures for interest rates and foreign currency exchange rates have not materially changed since the 2020 Form 10-K - Information regarding financial instruments sensitive to interest rate and foreign currency exchange rate changes has **not materially changed** since the 2020 Form 10-K[136](index=136&type=chunk) [Controls and Procedures](index=28&type=section&id=ITEM%204.%20CONTROLS%20AND%20PROCEDURES) Management concluded that disclosure controls and procedures were effective, with no material changes to internal controls - The Principal Executive Officer and Principal Financial Officer concluded that disclosure controls and procedures were **effective** as of April 30, 2021[137](index=137&type=chunk) - There were **no changes** in internal control over financial reporting during the quarter that materially affected, or are reasonably likely to materially affect, internal controls[138](index=138&type=chunk) [PART II – OTHER INFORMATION](index=29&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) [Legal Proceedings](index=29&type=section&id=ITEM%201.%20LEGAL%20PROCEEDINGS) The company refers to the 'Contingencies' note for legal matters, which are not expected to have a material adverse effect - For discussion of legal matters, the report refers to the Contingencies note in the financial statements[141](index=141&type=chunk) [Risk Factors](index=29&type=section&id=ITEM%201A.%20RISK%20FACTORS) The report refers to the 2020 Form 10-K for risk factors, noting they may be exacerbated by the COVID-19 pandemic - The company advises that risk factors disclosed in the 2020 Form 10-K should be considered, and notes that the **COVID-19 pandemic may exacerbate these risks**[142](index=142&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=29&type=section&id=ITEM%202.%20UNREGISTERED%20SALES%20OF%20EQUITY%20SECURITIES%20AND%20USE%20OF%20PROCEEDS) The company repurchased 114,598 common shares in Q2 2021, with $422.3 million remaining available for future repurchases - As of April 30, 2021, approximately **$422.3 million remained available** for share repurchases under the company's authorized programs[143](index=143&type=chunk) Common Stock Repurchases (Q2 2021) | Period | Total Shares Purchased | Average Price Paid per Share | |:---|:---:|:---:| | February 2021 | 50,527 | $186.48 | | March 2021 | 36,834 | $198.57 | | April 2021 | 27,237 | $205.45 | | **Total** | **114,598** | **-** | [Exhibits](index=30&type=section&id=ITEM%206.%20EXHIBITS) This section lists all exhibits filed with the Form 10-Q, including agreements, plans, and required officer certifications